M. Kyle Jensen
( out of 20 reviews )

M. Kyle Jensen, MD, MS

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

Primary Children's Hospital Outpatient Services at Riverton

3773 West 12600 South
Riverton , UT 84065
801-213-3599
Get Directions

Dr. Jensen completed his medical school at the University of Utah, then pediatric residency at Primary Children’s Hospital. He completed a Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at the Children’s Hospital of Wisconsin then completed an Advanced Pediatric Hepatology and Transplant Hepatology Fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Jensen is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.

He is Professor of Pediatrics at the University of Utah in the Division of Pediatric Gastroenterology at Primary Children´s Hospital. His primary clinical interests are in pediatric liver disease and caring for children who need liver transplantation.

Dr. Jensen’s research interests include pediatric liver disease and outcomes and quality research in transplantation and pediatric gastroenterology, with an emphasis in epidemiology.

Specialties

Board Certification

American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Gastroenterology)
Pediatric Transplant Hepatolgoy - Subspecialty

Patient Rating

Patients consistently praise Dr. Jensen as compassionate, patient, and personable. Commenters say he listens carefully, takes time to answer questions, and explains conditions and treatments clearly and thoroughly, which helps families feel confident and comfortable. Several reviews also note his medical knowledge, concern for mental as well as physical health, and that he goes above and beyond in care.

Generated via Patient Reviews

5.0 /5
( out of 20 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Dr. Jensen completed his medical school at the University of Utah, then pediatric residency at Primary Children’s Hospital. He completed a Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at the Children’s Hospital of Wisconsin then completed an Advanced Pediatric Hepatology and Transplant Hepatology Fellowship at Cincinnati Children’s Hospital Medical Center. Dr. Jensen is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.

He is Professor of Pediatrics at the University of Utah in the Division of Pediatric Gastroenterology at Primary Children´s Hospital. His primary clinical interests are in pediatric liver disease and caring for children who need liver transplantation.

Dr. Jensen’s research interests include pediatric liver disease and outcomes and quality research in transplantation and pediatric gastroenterology, with an emphasis in epidemiology.

Board Certification and Academic Information

Academic Departments Pediatrics -Professor (Clinical)
Academic Divisions Gastroenterology, Hepatology, & Nutrition
Board Certification
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Pediatric Gastroenterology)
Pediatric Transplant Hepatolgoy - Subspecialty

Education history

Fellowship Advanced Hepatology - Cincinnati Children’s Hospital & Medical Center Fellow
Graduate Training Epidemiology/Clinical and Translational Science - Medical College of Wisconsin M.S.
Fellowship Pediatric Gastroenterology - Medical College of Wisconsin/Children’s Hospital of Wisconsin Fellow
Residency Pediatrics - University of Utah, Primary Children’s Medical Center Resident
Professional Medical Medicine - University of Utah School of Medicine M.D.
Undergraduate University of Wyoming B.S.

Selected Publications

Journal Article

  1. Denier D, Peng YE, Amin M, Aumar M, Auth M, Druve Tavares Fagundes E, El-Matary W, Ferreira AR, Furuya KN, Gupta N, Guthery S, Horslen S, Jensen MK, Kamath BM, Koot BGP, Loomes KM, Mack C, Martinez M, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Stevens JP, Tessier ME, Valentino P, Deneau M, Liu K, Ricciuto A (2026). Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing Cholangitis. JHEP Rep, 101940.
  2. Diamond T, Chapin CA, Diorio CJ, McCuaig S, Lau M, Chu N, Gibson NM, Kreiger PA, Horslen S, Loomes KM, Banc-Husu AM, Chu J, Jensen MK, Leung DH, Narang A, Carter BA, Elisofon S, Fischer R, Lobritto SJ, Leonis M, Peters AL, Rodriguez-Baez N, Romero R, Rosenthal P, Rudnick D, Squires J, Sundaram S, Tolliver KM, Valentino P, Durkalski V, Alonso EM, Behrens EM (2026). CD8 TRM-like T cells expressing perforin and IFN-γ define a pediatric activated T-cell acute liver failure endotype. Hepatol Commun, 10(4).
  3. Bass LM (2026). Secondary prophylaxis of variceal hemorrhage in biliary atresia—Analysis of prospective multicenter studies. J Pediatr Gastroenterol Nutr, 82(2), 383-388.
  4. Perez CFM, Vandriel SM, Gonzales EM, Wang JS, Li LT, She H, Jankowska I, Czubkowski P, Gliwicz-Miedziska D, Jacquemin E, Bouligand J, DAntiga L, Nicastro E, Fischler B, Arnell H, Siew SM, Stormon M, Loomes KM, Piccoli DA, Rand EB, Squires JE, Karpen SJ, Romero R, Kasahara M, nal Z, Sokal, Demaret T, Wiecek S, Lacaille F, Debray D, Hardikar W, Shankar S, Valentino PL, Sundaram SS, Ebel NH, Feinstein JA, Waisbourd-Zinman O, Lin HC, Rock N, Verkade HJ, Jensen MK, Jaramillo C, Kim KM, Oh SH, Brecemiclj J, Alam S, Indolfi G, Blondet N, Fawaz R, Nastasio S, Calvo PL, Nebbia G, Arikan C, Larson-Nath C, Zizzo AN, Sandahl TD, Tzivinikos C, El-Koofy NM, Elmonem MA, Aqul AA, Karnsakul W, Bulut P, Kerkar N, Wolters VM, Roberts AJ, Evans HM, Sanchez MC, Cavalieri ML, Kelly DA, Hartley J, Lee WS, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Bernabeu JQ, Quiros-Tejeira RE, Ferreira CT, Carvalho E, Eshun J, Zellos A, Dezsfi A, Pinto RB, Schwarz K, Rogalidou M, Garcia J, Tamara ML, Beretta M, Mujawar Q, Santos-Silva E, Busoms CM, Lurz E, Gonalves C, Jimenez-Rivera C, Banales JM, Thompson RJ, Hansen BE, Kamath BM, Global ALagille Alliance GALA Study Group (2025). Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group. Liver Int, 45(12), e70423.
  5. Huysentruyt K, Vandriel SM, Roelants M, Piccoli DA, Loomes KM, Rand EB, Ebel NH, Feinstein JA, Jankowska I, Czubkowski P, Gliwicz-Miedzinska D, Gonzales EM, Jacquemin E, Bouligand J, Karpen SJ, Romero R, Lin HC, Fischler B, Arnell H, Li LT, Wang JS, Fawaz R, Nastasio S, Kim KM, Oh SH, DAntiga L, Nicastro E, Fischer RT, Siew SM, Stormon M, Lertudomphonwanit C, Hardikar W, Shankar S, Squires JE, Sundaram SS, Larson-Nath C, Kelly DA, Hartley J, Bulut P, Jensen MK, Jaramillo C, Roberts AJ, Evans HM, Sokal M, Demaret T, Verkade HJ, Thompson RJ, Hansen BE, Cole TJ, Kamath BM, Debray D, Lacaille F, Brecelj J, El-Koofy NM, Elmonem MA, Lee WS, Sanchez MC, Cavalieri ML, Hajinicolaou C, Schwarz KB, Carvalho E, Rock N, Karnsakul W, Quiros-Tejeira RE, Alam S, Nebbia G, Mozer-Glassberg Y, Valentino PL, Santos-Silva E, nal Z, Dezsofi-Gottl A, Melere M, Legarda Tamara M, Eshun J, Zellos A, Indolfi G, Rogalidou M, Blondet N, Luigi Calvo P, Beretta M, Zizzo AN, Arikan C, Kasahara M, Kerkar N, Aqul AA, Wolters VM, Borges Pinto R, Quintero Bernabeu J, Garcia J, Wiecek S, Tzivinikos C, Mujawar Q, Jimenez-Rivera C, Molera Busoms C, Gonalves C, Bujanda L, Global Alagille Alliance GALA Study Group (2025). Condition-Specific Growth Charts for Children With Alagille Syndrome. JAMA Netw Open, 8(11), e2545294.
  6. Shneider BL, Kanchi RS, Grimm SL, Devaraj S, Emamaullee J, Schraw J, Lupo PJ, Bezerra JA, Loomes KM, Magee JC, Sokol RJ, Wang KS, Kriegmeier A, Hsu E, Molleston JP, Rosenthal P, Kohli R, Karpen SJ, Horslen SP, Jensen MK, Barbetta A, Coarfa C, Childhood Liver Disease Research Network (2025). Plasma proteome correlations with liver stiffness in pediatric cholestasis implicate epithelial to mesenchymal transition. Hepatol Commun, 9(10).
  7. Shneider BL, Goodrich NP, Ye W, Molleston JP, Leung DH, Sokol RJ, Cavallo L, Wang K, Valentino PL, Teckman JH, Squires JE, Sundaram SS, Rosenthal P, Romero R, Miethke AG, Loomes KM, Kohli R, Karpen SJ, Kamath BM, Jensen MK, Bezerra JA, Bass LM, Magee JC, ChiLDReN (2025). Prospective Multicenter Longitudinal Measurement of Liver Stiffness in School-Age Children With Cholestatic Liver Disease. Gastro Hep Adv, 4(10), 100788.
  8. Vandriel SM, Li LT, She H, Wang JS, Loomes KM, Piccoli DA, Jankowska I, Czubkowski P, Gliwicz-Miedziska D, DAntiga L, Nicastro E, Lacaille F, Debray D, Sokal M, Demaret T, Fawaz RL, Nastasio S, Kim KM, Oh SH, Fischler B, Arnell H, Larson-Nath C, Hardikar W, Shankar S, Sundaram SS, Chaidez A, Bulut P, Calvo PL, Kasahara M, Blondet N, Lurz E, Kavallar AM, Gonzales EM, Jacquemin E, Bouligand J, Ebel NH, Feinstein JA, Siew SM, Stormon MO, Karpen SJ, Romero R, Jensen MK, Jaramillo C, Squires JE, Bedoyan SM, Kelly DA, Hartley J, Verkade HJ, Lee WS, Lertudomphonwanit C, Fischer RT, Lin HC, Rock N, Mozer-Glassberg Y, Roberts AJ, Evans HM, Karnsakul W, Nebbia G, Wolters VM, Valentino PL, Bernabeu JQ, Aqul AA, Arikan C, Tamara ML, Busoms CM, Sandahl TD, Indolfi G, Zizzo AN, Zellos A, Quiros-Tejeira RE, Santos-Silva E, Schwarz KB, Brecelj J, Sanchez MC, Cavalieri ML, Tzivinikos C, Wiecek S, Eshun J, Kerkar N, Mujawar Q, nal Z, Gonalves C, Garcia J, Alam S, Jimenez-Rivera C, Bujanda L, Thompson RJ, Hansen BE, Spinner NB, Gilbert MA, Kamath BM, Global ALagille Alliance GALA Study Group (2025). Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines. Liver Int, 45(9), e70251.
  9. Jensen MK, Gallegos-Orozco JF (2025). Less salt and more water for children-not just dietary, but transplant management too. Liver Transpl, 31(5), 569-570.
  10. Kahan AM, Holley AG, Horns J, Jaramillo C, Jensen MK, Russell KW, Nelson RE, Brooke BS, Guthery S, Kastenberg ZJ (2025). The Age-stratified Cost of Biliary Atresia: A MarketScan®-Based Cost Analysis. J Pediatr Surg, 60(5), 162244.
  11. Shneider BL (2025). Prospective Multicenter Longitudinal Measurement of Liver Stiffness in School-Age Children With Cholestatic Liver Disease. Gastro Hep Adv, 4(10).
  12. Tessier MEM, Schraw JM, Beer S, Harpavat S, Kyle Jensen M, Magee JC, Ng V, Scheurer ME, Taylor SA, Shneider BL (2024). The association of human milk intake and outcomes in biliary atresia. J Pediatr Gastroenterol Nutr.
  13. Guthery SL, Kyle Jensen M, Sean Esplin M, OBrien E, Krong J, Srivastava R (2024). Feasibility of biliary atresia newborn screening in an integrated health network. J Pediatr Gastroenterol Nutr, 79(5), 954-961.
  14. Ricciuto A, Liu K, El-Matary W, Amin M, Amir AZ, Aumar M, Auth M, Di Guglielmo MD, Druve Tavares Fagundes E, Rodrigues Ferreira A, Furuya KN, Gupta N, Guthery S, Horslen SP, Jensen K, Kamath BM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Mack C, Martinez M, Montano-Loza A, Ovchinsky N, Papadopoulou A, Perito ER, Sathya P, Schwarz KB, Shah U, Shteyer E, Soufi N, Stevens JP, Taylor A, Tessier ME, Valentino P, Woynarowski M, Deneau M, Pediatric PSC Consortium (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC Consortium. Aliment Pharmacol Ther.
  15. Hansen BE, Vandriel SM, Vig P, Garner W, Mogul DB, Loomes KM, Piccoli DA, Rand EB, Jankowska I, Czubkowski P, Gliwicz-Miedziska D, Gonzales EM, Jacquemin E, Bouligand J, DAntiga L, Nicastro E, Arnell H, Fischler B, Sokal, Demaret T, Siew S, Stormon M, Karpen SJ, Romero R, Ebel NH, Feinstein JA, Roberts AJ, Evans HM, Sundaram SS, Chaidez A, Hardikar W, Shankar S, Fischer RT, Lacaille F, Debray D, Lin HC, Jensen MK, Jaramillo C, Karthikeyan P, Indolfi G, Verkade HJ, Larson-Nath C, Quiros-Tejeira RE, Valentino PL, Rogalidou M, Dezsfi A, Squires JE, Schwarz K, Calvo PL, Bernabeu JQ, Zizzo AN, Nebbia G, Bulut P, Santos-Silva E, Fawaz R, Nastasio S, Karnsakul W, Tamara ML, Busoms CM, Kelly DA, Sandahl TD, Jimenez-Rivera C, Banales JM, Mujawar Q, Li LT, She H, Wang JS, Kim KM, Oh SH, Sanchez MC, Cavalieri ML, Lee WS, Hajinicolaou C, Lertudomphonwanit C, Waisbourd-Zinman O, Arikan C, Alam S, Carvalho E, Melere M, Eshun J, nal Z, Desai DM, Wiecek S, Pinto RB, Wolters VM, Garcia J, Beretta M, Kerkar N, Brecelj J, Rock N, Lurz E, Blondet N, Shah U, Thompson RJ, Kamath BM, Global ALagille Alliance GALA Study Group (2023). Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA. Hepatology.
  16. Lopez-Verdugo F, Sanchez-Garcia J, Baraki S, Kastenberg ZJ, Sanchez-Garavito JE, Zendejas I, Alonso D, Jensen MK, Fujita S, Meyers RL, Book L, Rodriguez-Davalos MI (2023). Utilization of Segmental Grafts is Associated With Higher Transplant Rates in Pediatric Patients. J Surg Res, 290, 28-35.
  17. Vandriel SM, Li LT, She H, Wang JS, Gilbert MA, Jankowska I, Czubkowski P, Gliwicz-Miedziska D, Gonzales EM, Jacquemin E, Bouligand J, Spinner NB, Loomes KM, Piccoli DA, DAntiga L, Nicastro E, Sokal, Demaret T, Ebel NH, Feinstein JA, Fawaz R, Nastasio S, Lacaille F, Debray D, Arnell H, Fischler B, Siew S, Stormon M, Karpen SJ, Romero R, Kim KM, Baek WY, Hardikar W, Shankar S, Roberts AJ, Evans HM, Jensen MK, Kavan M, Sundaram SS, Chaidez A, Karthikeyan P, Sanchez MC, Cavalieri ML, Verkade HJ, Lee WS, Squires JE, Hajinicolaou C, Lertudomphonwanit C, Fischer RT, Larson-Nath C, Mozer-Glassberg Y, Arikan C, Lin HC, Bernabeu JQ, Alam S, Kelly DA, Carvalho E, Ferreira CT, Indolfi G, Quiros-Tejeira RE, Bulut P, Calvo PL, nal Z, Valentino PL, Desai DM, Eshun J, Rogalidou M, Dezsfi A, Wiecek S, Nebbia G, Pinto RB, Wolters VM, Tamara ML, Zizzo AN, Garcia J, Schwarz K, Beretta M, Sandahl TD, Jimenez-Rivera C, Kerkar N, Brecelj J, Mujawar Q, Rock N, Busoms CM, Karnsakul W, Lurz E, Santos-Silva E, Blondet N, Bujanda L, Shah U, Thompson RJ, Hansen BE, Kamath BM, Global ALagille Alliance GALA Study Group (2022). Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Hepatology, 77(2), 512-529.
  18. Leung DH, Devaraj S, Goodrich NP, Chen X, Rajapakshe D, Ye W, Andreev V, Minard CG, Guffey D, Molleston JP, Bass LM, Karpen SJ, Kamath BM, Wang KS, Sundaram SS, Rosenthal P, McKiernan P, Loomes KM, Jensen MK, Horslen SP, Bezerra JA, Magee JC, Merion RM, Sokol RJ, Shneider BL, Alonso E, Bass L, Kelly S, Riordan M, Melin-Aldana H, Bezerra J, Bove K, Heubi J, Miethke A, Tiao G, Denlinger J, Chapman E, Sokol R, Feldman A, Mack C, Narkewicz M, Suchy F, Sundaram SS, Van Hove J, Garcia B, Kauma M, Kocher K, Steinbeiss M, Lovell M, Loomes KM, Piccoli D, Rand E, Russo P, Spinner N, Erlichman J, Stalford S, Pakstis D, King S, Squires R, Sindhi R, Venkat V, Bukauskas K, McKiernan P, Haberstroh L, Squires J, Rosenthal P, Bull L, Curry J, Langlois C, Kim G, Teckman J, Kociela V, Nagy R, Patel S, Cerkoski J, Molleston JP, Bozic M, Subbarao G, Klipsch A, Sawyers C, Cummings O, Horslen SP, Murray K, Hsu E, Cooper K, Young M, Finn L, Kamath BM, Ng V, Quammie C, Putra J, Sharma D, Parmar A, Guthery S, Jensen K, Rutherford A, Lowichik A, Book L, Meyers R, Hall T, Wang KS, Michail S, Thomas D, Goodhue C, Kohli R, Wang L, Soufi N, Thomas D, Karpen S, Gupta N, Romero R, Vos MB, Tory R, Berauer JP, Abramowsky C, McFall J, Shneider BL, Harpavat S, Hertel P, Leung D, Tessier M, Schady D, Cavallo L, Olvera D, Banks C, Tsai C, Thompson R, Doo E, Hoofnagle J, Sherker A, Torrance R, Hall S, Magee J, Merion R, Spino C, Ye W, Childhood Liver Disease Research Network (2022). Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology, 77(2), 530-545.
  19. Conover KR, Absah I, Ballal S, Brumbaugh D, Cho S, Cardenas MC, Knackstedt ED, Goyal A, Jensen MK, Kaplan JL, Kellermayer R, Kociolek LK, Michail S, Oliva-Hemker M, Reed AW, Weatherly M, Kahn SA, Nicholson MR (2023). FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIOIDES DIFFICILE INFECTION IN IMMUNOCOMPROMISED PEDIATRIC PATIENTS. J Pediatr Gastroenterol Nutr, 76(4), 440-446.
  20. Kastenberg ZJ, Deneau MR, OBrien EA, Huynh K, Book LS, Srivastava R, Jensen MK, Jaramillo CM, Guthery SL (2023). Fractionated Bilirubin Among 252 892 Utah Newborns with and Without Biliary Atresia: A 15-year Historical Birth Cohort Study. J Pediatr, 257, 113339.
  21. Bass LM, Ye W, Hawthorne K, Leung DH, Murray KF, Molleston JP, Romero R, Karpen S, Rosenthal P, Loomes KM, Wang KS, Squires RH, Miethke A, Ng VL, Horslen S, Kyle Jensen M, Sokol RJ, Magee JC, Shneider BL, ChiLDReN (2022). Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia. Hepatology, 76(3), 712-726.
  22. Lerret SM, Flynn E, White-Traut R, Alonso E, Mavis AM, Jensen MK, Peterson CG, Schiffman R (2022). Acceptability of an mHealth Family Self-management Intervention (myFAMI) for Pediatric Transplantation Families: Qualitative Focus. JMIR Nurs, 5(1), e39263.
  23. Shneider BL, Spino CA, Kamath BM, Magee JC, Ignacio RV, Huang S, Horslen SP, Molleston JP, Miethke AG, Kohli R, Leung DH, Jensen MK, Loomes KM, Karpen SJ, Mack C, Rosenthal P, Squires RH, Baker A, Rajwal S, Kelly D, Sokol RJ, Thompson RJ, for ChiLDReN and UK IMAGOIMAGINE Investigators (2022). Impact of long-term administration of maralixibat on children with cholestasis secondary to Alagille syndrome. Hepatol Commun, 6, 1922-1933.
  24. Nicholson MR, Alexander E, Ballal S, Davidovics Z, Docktor M, Dole M, Gisser JM, Goyal A, Hourigan SK, Jensen MK, Kaplan JL, Kellermayer R, Kelsen JR, Kennedy MA, Khanna S, Knackstedt ED, Lentine J, Lewis JD, Michail S, Mitchell PD, Oliva-Hemker M, Patton T, Queliza K, Sidhu S, Solomon AB, Suskind DL, Weatherly M, Werlin S, de Zoeten EF, Kahn SA, North American Society of Pediatric Gastroenterology and Nutrition Fecal Microbiota Transplantation Special Interest Group (2021). Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease. J Crohns Colitis, 16, 768-777.
  25. Jaramillo C, Jensen MK, McClain A, Stoddard G, Barnhart D, Ermarth AK (2020). Clinical diagnostic predictive score for Meckel diverticulum. J Pediatr Surg, 56(9), 1673-1677.
  26. Lerret SM, Schiffman R, White-Traut R, Medoff-Cooper B, Ahamed SI, Adib R, Liegl M, Alonso E, Mavis A, Jensen K, Peterson CG, Neighbors K, Riordan MK, Semp MC, Vo T, Stendahl G, Chapman S, Unteutsch R, Simpson P (2021). Feasibility and Acceptability of a mHealth Self-Management Intervention for Pediatric Transplant Families. West J Nurs Res, 1939459211024656.
  27. Nicholson MR, Hourigan SK, Conrad M, Goyal A, Jensen K, Kelsen J, Kennedy M, Weatherly M, Kahn SA (2021). Current Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children. Am J Gastroenterol.
  28. Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammad S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery SL (2020). The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology, 73(3), 1074-1087.
  29. Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery SL (2020). Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. Hepatology, 73(3), 1061-1073.
  30. Venkat V, Ng VL, Magee JC, Ye W, Hawthorne K, Harpavat S, Molleston JP, Murray KF, Wang KS, Soufi N, Bass LM, Alonso EM, Bezerra JA, Jensen MK, Kamath BM, Loomes KM, Mack CL, Rosenthal P, Shneider BL, Squires RH, Sokol RJ, Karpen SJ, Childhood Liver Disease Research Network (2020). Modeling Outcomes in Children With Biliary Atresia With Native Liver After 2 Years of Age. Hepatol Commun, 4(12), 1824-1834.
  31. Shneider BL, Goodrich NP, Ye W, Sawyers C, Molleston JP, Merion RM, Leung DH, Karpen SJ, Kamath BM, Cavallo L, Wang K, Teckman JH, Squires JE, Sundaram SS, Rosenthal P, Romero R, Murray KF, Loomes KM, Jensen MK, Bezerra JA, Bass LM, Sokol RJ, Magee JC, Childhood Liver Disease Research Network ChiLDReN (2020). Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease. Hepatol Commun, 4(11), 1694-1707.
  32. Kamath BM (2020). Unraveling the Relationship Between Itching, Scratch Scales, and Biomarkers in Children With Alagille Syndrome. Hepatol Commun, 4(7), 1012-1018.
  33. Nicholson MR, Mitchell PD, Alexander E, Ballal S, Bartlett M, Becker P, Davidovics Z, Docktor M, Dole M, Felix G, Gisser J, Hourigan SK, Jensen MK, Kaplan JL, Kelsen J, Kennedy M, Khanna S, Knackstedt E, Leier M, Lewis J, Lodarek A, Michail S, Oliva-Hemker M, Patton T, Queliza K, Russell GH, Singh N, Solomon A, Suskind DL, Werlin S, Kellermayer R, Kahn SA (2019). Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. Clin Gastroenterol Hepatol, 18(3), 612-619.e1.
  34. Jaramillo C, Guthery SL, Lowichik A, Stoddard G, Kim T, Li Y, Jensen MK (2019). Quantitative Liver Fibrosis Using Collagen Hybridizing Peptide to Predict Native Liver Survival in Biliary Atresia: A Pilot Study. J Pediatr Gastroenterol Nutr, 70(1), 87-92.
  35. Deneau MR, Valentino PL, Mack C, Alqoaer K, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, El-Matary W, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Kim KM, Kolho KL, Koot B, Iorio R, Martinez M, Miloh T, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Woynarowski M, Guthery S (2019). Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. J Pediatr Gastroenterol Nutr, 70(1), e12-e17.
  36. Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen MK (2019). Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. J Pediatr, 209, 92-96.e1.
  37. Laborda TJ, Jensen MK, Kavan M, Deneau M (2019). Treatment of primary sclerosing cholangitis in children. World J Hepatol, 11(1), 19-36.
  38. Davidovics, Zev H, Michail, Sonia, Nicholson, Maribeth R, Kociolek, Larry K, Pai, Nikhil, Hansen, Richard, Schwerd, Tobias, Maspons, Aldo, Shamir, Raanan, Szajewska, Hania, Thapar, Nikhil, de Meij, Tim, Mosca, Alexis, Vandenplas, Yvan, Kahn, Stacy A, Kellermayer, Richard, and the FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology (12/11/2018). Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr.
  39. Barfuss S, Knackstedt ED, Jensen K, Molina K, Lal A (2018). Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection. Transpl Infect Dis, 20(6), e12983.
  40. Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis. Hepatol Commun, 2(11), 1369-1378.
  41. Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK (2017). The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology, 66(2), 518-527.
  42. Lascurain L, Jensen MK, Guthery SL, Holmen J, Deneau M (2016). Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis. Inflamm Bowel Dis, 22(1), 146-50.
  43. Varier RU, Biltaji E, Smith KJ, Roberts MS, Jensen MK, LaFleur J, Nelson RE (2015). Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Infect Control Hosp Epidemiol, 36(4), 438-444.
  44. Elizabeth Parsons C, Nelson R, Book LS, Kyle Jensen M (2014). Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation: a case-control study. Liver Transpl, 20(12), 1468-74.
  45. Deneau M, Book LS, Guthery SL, Jensen MK (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. J Pediatr, 164(4), 714-719.e2.
  46. Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology, 58(4), 1392-400.
  47. Jensen MK, Campbell KM, Alonso MH, Nathan JD, Ryckman FC, Tiao GM (2013). Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl, 19(3), 315-21.
  48. Jensen MK, Biank VF, Moe DC, Simpson PM, Li SH, Telega GW (2012). HIDA, percutaneous transhepatic cholecysto-cholangiography and liver biopsy in infants with persistent jaundice: can a combination of PTCC and liver biopsy reduce unnecessary laparotomy? Pediatr Radiol, 42(1), 32-9.
  49. Jensen MK, Tipnis NA, Bajorunaite R, Sheth MK, Sato TT, Noel RJ (2010). Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. Gastrointest Endosc, 72(1), 95-102.

Review

  1. Laborda TJ, Jensen MK, Kavan M, Deneau M (2019). Treatment of primary sclerosing cholangitis in children. [Review]. World J Hepatol, 11(1), 19-36.

Book Chapter

  1. Jensen MK (2021). Liver Transplantation in Children: Indications and Surgical Aspects. In Jensen M.K. (Ed.), Liver Disease in Children Fifth Edition (pp. 801-815).
  2. Jensen MK, Balistreri WF (2015). Viral Hepatitis. In Robert Kliegman, Bonita Stanton, Richard Behrman, Joseph St. Geme and Nina Schor (Eds.), Nelson Textbook of Pediatrics (20, pp. 1942-53). Philadelpha: Elsevier.
  3. Sampert C, Jensen MK (2014). Esophageal Varices. In Pohl / Jolley / Gelfond (Ed.), Pediatric Gastroenterology – A Color Handbook (1st). London: Manson Publishing.
  4. Jensen MK, Alonso MA, Nathan JD, Ryckman FC, Tiao G, Balistreri WF (2014). Liver Transplantation in Children: Indications and Surgical Aspects. In Suchy, Sokol, Balistreri WF (Eds.), Liver disease in Children (4th, pp. 760-772). Cambridge, UK: Cambridge University Press.
  5. Kyle Jensen M (2011). Liver transplantation in children: Indications and surgical aspects. In Kyle Jensen M. (Ed.), Liver Disease in Children Fourth Edition (pp. 760-772).
  6. Jensen MK, Telega G (2008). Infections of the Liver and Biliary Tract. In Rudolph, Lister, Gershon, First, Rudolph (Eds.), Rudolph’s Pediatrics (22nd). New York, New York: McGraw-Hill.

Letter

  1. Lerret SM (2022). Acceptability of an mHealth Family Self-management Intervention (myFAMI) for Pediatric Transplantation Families: Qualitative Focus [Letter to the editor]. JMIR Nurs, 5(1).
  2. Ermarth A, Jensen MK (2020). A North American Serologic-based Celiac Disease Diagnosis: If Not Now, Then When? [Letter to the editor]. J Pediatr Gastroenterol Nutr, 70(5), e107.

Abstract

  1. Pachal P, Kahn S, Zellmer C, Kassam Z, Osman M, Allegretti J, Seng M, Budree, AB, NASPGHAN FMT Special Interest Group (11/26/2018). Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis. [Abstract]. Open Forum Infectious Disease, 5(suppl_1), 197.